PT Jayamas Medica Industri Tbk (OMED.JK)
IDR 184.0
(-2.14%)
IDR 184.0
(-2.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|
| Revenue | 1736.98 Billion | 1739.05 Billion | 2226.57 Billion | 1994.53 Billion | 1228.04 Billion |
| Cost of Revenue | 1184.98 Billion | 1175.98 Billion | 1322.27 Billion | 957.59 Billion | 782.57 Billion |
| Gross Profit | 551.99 Billion | 563.07 Billion | 904.29 Billion | 1036.94 Billion | 445.47 Billion |
| Operating Expenses | 249.36 Billion | 190.83 Billion | 171.19 Billion | 189.13 Billion | -3.33 Billion |
| Selling, General and Administrative Expenses | 250 Billion | 84.26 Billion | 61.92 Billion | 87.71 Billion | 149.96 Billion |
| Research and Development Expenses | - | - | - | 715.1 Million | 514.7 Million |
| Other Expenses | -632.52 Million | 3.76 Billion | 799.09 Million | 2.44 Billion | -3.33 Billion |
| Cost and Expenses | 1434.42 Billion | 1366.81 Billion | 1493.47 Billion | 1146.73 Billion | -3.33 Billion |
| Operating Income | 302.56 Billion | 378.94 Billion | 734.46 Billion | 854.21 Billion | 3.33 Billion |
| Interest Expense | 19.92 Billion | 20.65 Billion | 21.7 Billion | 9 Billion | 531.55 Million |
| Income Tax Expense | 65.18 Billion | 81.6 Billion | 158.82 Billion | 167.13 Billion | 74.26 Billion |
| Earnings before Tax | 326.16 Billion | 372.1 Billion | 729.2 Billion | 860 Billion | 302.28 Billion |
| Net Income | 259.35 Billion | 285.78 Billion | 562.69 Billion | 685.5 Billion | 226.2 Billion |
| Earnings Per Share Basic | 9.59 | 10.56 | 20.80 | 25.33 | 4.43 |
| Earnings Per Share Diluted | 9.59 | 10.56 | 20.80 | 25.33 | 4.43 |
| Weighted Average Shares Outstanding | 27.05 Billion | 27.05 Billion | 27.05 Billion | 27.05 Billion | 51.11 Billion |
| Weighted Average Shares Outstanding (Diluted) | 27.05 Billion | 27.05 Billion | 27.05 Billion | 27.05 Billion | 51.11 Billion |
| Gross Margin | 0.32 | 0.32 | 0.41 | 0.52 | 0.36 |
| EBIT Margin | 0.21 | 0.24 | 0.35 | 0.44 | 0.00 |
| Profit Margin | 0.15 | 0.16 | 0.25 | 0.34 | 0.18 |
| EBITDA | 371.38 Billion | 415.7 Billion | 768.19 Billion | 872.21 Billion | 305.78 Billion |
| Earnings Before Tax Margin | 0.17 | 0.22 | 0.33 | 0.43 | 0.00 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 452.25 Billion | 427.38 Billion | 470.51 Billion | 1736.98 Billion | 455.12 Billion | 414.44 Billion |
| Cost of Revenue | 298.91 Billion | 288.68 Billion | 318.17 Billion | 1184.98 Billion | 319.43 Billion | 278.34 Billion |
| Gross Profit | 153.34 Billion | 138.7 Billion | 152.34 Billion | 551.99 Billion | 135.69 Billion | 136.1 Billion |
| Operating Expenses | 72.78 Billion | 61.15 Billion | 64.43 Billion | 251.12 Billion | 60.22 Billion | 68 Billion |
| Selling, General and Administrative Expenses | 30.89 Billion | 23.43 Billion | 28.57 Billion | - | 28.33 Billion | 26 Billion |
| Research and Development Expenses | - | - | - | - | - | - |
| Other Expenses | -6.24 Billion | - | - | - | - | - |
| Cost and Expenses | 371.69 Billion | 349.84 Billion | 382.6 Billion | 1436.11 Billion | 379.65 Billion | 346.34 Billion |
| Operating Income | 87.94 Billion | 77.06 Billion | 93.3 Billion | 302.56 Billion | 80.82 Billion | 65.37 Billion |
| Interest Expense | 4.6 Billion | 4.66 Billion | 5.76 Billion | 19.41 Billion | 4.55 Billion | 4.57 Billion |
| Income Tax Expense | 18.92 Billion | 18.1 Billion | 24.45 Billion | 65.18 Billion | 14.54 Billion | 15.15 Billion |
| Earnings before Tax | 100.08 Billion | 82.19 Billion | 101.95 Billion | 326.16 Billion | 86.38 Billion | 69.82 Billion |
| Net Income | 80.48 Billion | 63.46 Billion | 76.97 Billion | 259.35 Billion | 71.77 Billion | 54.18 Billion |
| Earnings Per Share Basic | 2.97 | 2.34 | 1.96 | - | 3.12 | 2.00 |
| Earnings Per Share Diluted | 2.97 | 2.34 | 1.96 | - | 3.12 | 2.00 |
| Weighted Average Shares Outstanding | 27.05 Billion | 27.05 Billion | 39.23 Billion | 27.05 Billion | 23 Billion | 27.05 Billion |
| Weighted Average Shares Outstanding (Diluted) | 27.05 Billion | 27.05 Billion | 39.23 Billion | 27.05 Billion | 23 Billion | 27.05 Billion |
| Gross Margin | 0.34 | 0.32 | 0.32 | 0.32 | 0.30 | 0.33 |
| EBIT Margin | 0.24 | 0.21 | 0.24 | - | 0.21 | 0.20 |
| Profit Margin | 0.18 | 0.15 | 0.16 | 0.15 | 0.16 | 0.13 |
| EBITDA | 109.34 Billion | 91.3 Billion | 115.12 Billion | - | 96.71 Billion | 80.93 Billion |
| Earnings Before Tax Margin | 0.19 | 0.18 | 0.20 | 0.17 | 0.18 | 0.16 |
CSCCF
0GC0
1003
LUMAXIND
CGTX
FMK